TSUMURA & CO.
4540 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区赤坂二丁目１７番１１号
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
TSUMURA & CO. is a prominent Japanese pharmaceutical company specializing in Kampo medicine, which integrates traditional herbal practices with modern health solutions. The company offers a range of products, including prescription Kampo formulations, over-the-counter medications, and herbal bath salts, promoting a holistic approach to well-being. TSUMURA & CO. aims to foster “Cho-WA” or harmony between the mind, body, and society, reflecting its commitment to sustainable practices that benefit individuals and the environment. With a focus on innovation rooted in tradition, the company strives to navigate the Kampo value chain responsibly, ensuring a sustainable future for both people and the planet. Additionally, TSUMURA publishes "The Journal of Japanese Botany," contributing to the scientific discourse in herbal medicine.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-08 07:37 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.7 KB | |
| 2025-07-01 09:20 |
Inside Information Statement
臨時報告書
|
Japanese | 27.7 KB | |
| 2025-06-24 06:22 |
Internal Control over Financial Reporting
内部統制報告書－第89期(2024/04/01－2025/03/31)
|
Japanese | 25.7 KB | |
| 2025-06-24 06:21 |
Annual Report
有価証券報告書－第89期(2024/04/01－2025/03/31)
|
Japanese | 3.5 MB | |
| 2025-06-24 06:21 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2025-06-11 06:35 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 27.8 KB | |
| 2025-05-12 07:16 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 28.0 KB | |
| 2025-04-07 07:10 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.9 KB | |
| 2025-03-10 07:05 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.1 KB | |
| 2025-03-03 08:27 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 30.2 KB | |
| 2025-02-20 07:30 |
Inside Information Statement
臨時報告書
|
Japanese | 27.8 KB | |
| 2024-11-08 07:11 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-11-08 07:08 |
Interim Report
半期報告書－第89期(2024/04/01－2025/03/31)
|
Japanese | 242.2 KB | |
| 2024-07-01 08:38 |
Inside Information Statement
臨時報告書
|
Japanese | 24.0 KB | |
| 2024-06-27 08:16 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |